The Lys140 residue and the third and fourth extracellular regions of the human endothelin-A receptor are critical for ligand binding and selectivity.
Answers are grounded in this paper and cite their sources.
Lys140 mutation disrupts ETA function; extends extracellular domain mapping in animal models but leaves open human therapeutic relevance.
To investigate the ligand-binding site of the human endothelin-A-receptor subtype (ETA), we have produced various chimeric and mutated receptors in chinese hamster ovary cells. The substitution of Lys140 with Ile located in the C-terminus of the second transmembrane region caused a 13-fold reduction in affinity for endothelin-1 (ET-1) and 3.6-fold lower Bmax than those values for the original receptor. Correspondingly, the mutated ETA receptor with the Lys140-->Ile substitution failed to induce an increase in the intracellular calcium concentration in the presence of 1 nM ET-1. Thus, the Lys140 in the ETA receptor is important in ligand binding. ETA and ETB receptors possess the ET isopeptides selective and non-selective binding activities, respectively. Displacement experiments and the binding of 125I-ET-3 to various chimera receptors demonstrated that both the third and fourth extracellular regions, including the flanking transmembrane regions, are responsible for the ligand-binding selectivity of the ETA receptor.
No takes yet. Share an insight, caveat, or question.
Adachi et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: